Skip to main content

Advertisement

SpringerLink
Log in

Testing the Timing: Time Factor in Radiation Treatment for Head and Neck Cancers

  • Head and Neck Cancer (L Licitra, Section Editor)
  • Published:
Current Treatment Options in Oncology Aims and scope Submit manuscript

Opinion statement

Overall radiation treatment time has long been recognized as an important factor in head and neck tumor control. The concern of tumor growth in waiting time either before starting radiotherapy or during treatment is substantial given its negative impact on clinical outcome. There is an overwhelming evidence that increasing the time to initiate treatment increases the tumor burden and worsens the prognosis. This effect is more pronounced especially in patients with an early stage cancer disease. Delay in treatment initiation is contributed by both health care- and patient-related factors. Health care-related factors include advancement in diagnostic modalities and transfer of patient to academic health care centers accompanied by delayed referrals and long-awaited appointments. Patient-related factors include delayed reporting time and socioeconomic factors. An efficient transition of care along with access of cancer care modalities to community health care centers will not only improve the quality of care in secondary health care centers but also help decrease the patient burden in tertiary centers. A quick and well-structured multidisciplinary appointment program is fundamental in shortening the time required for patient referrals, thus increasing the optimal survival time for Head and Neck cancer patients with early initiation of treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Overgaard J, Alsner J, Eriksen J, Horsman MR, Grau C. Importance of overall treatment time for the response to radiotherapy in patients with squamous cell carcinoma of the head and neck. Rays. 2000;25(3):313–9.

    CAS  PubMed  Google Scholar 

  2. Mackillop WJ, Zhou S, Groome P, Dixon P, Cummings BJ, Hayter C, et al. Changes in the use of radiotherapy in Ontario 1984–1995. Int J Radiat Oncol Biol Phys. 1999;44(2):355–62.

    Article  CAS  PubMed  Google Scholar 

  3. Klausen OG, Olofsson J, Rosengren B. [A long waiting time for radiotherapy. Not acceptable for patients with neoplasms]. Tidsskrift for den Norske laegeforening: tidsskrift for praktisk medicin, ny raekke 1989;109 (23):2324–5.

  4. Ash D, Barrett A, Hinks A, Squire C. Royal College of R. Re-audit of radiotherapy waiting times 2003. Clin Oncol. 2004;16(6):387–94.

    Article  CAS  Google Scholar 

  5. Denham JW, Hamilton CS, Joseph DJ. How should a waiting list for treatment be managed? Australas Radiol. 1992;36(3):274–5.

    Article  CAS  PubMed  Google Scholar 

  6. Esco R, Palacios A, Pardo J, Biete A, Carceller JA, Veiras C, et al. Infrastructure of radiotherapy in Spain: a minimal standard of radiotherapy resources. Int J Radiat Oncol Biol Phys. 2003;56(2):319–27.

    Article  CAS  PubMed  Google Scholar 

  7. Gabriele P, Malinverni G, Bona C, Manfredi M, Delmastro E, Gatti M, et al. Are quality indicators for radiotherapy useful in the evaluation of service efficacy in a new based radiotherapy institution? Tumori. 2006;92(6):496–502.

    PubMed  Google Scholar 

  8. Jensen AR, Nellemann HM, Overgaard J. Tumor progression in waiting time for radiotherapy in head and neck cancer. Radiother Oncol. 2007;84(1):5–10.

    Article  PubMed  Google Scholar 

  9. Mackillop WJ, Fu H, Quirt CF, Dixon P, Brundage M, Zhou Y. Waiting for radiotherapy in Ontario. Int J Radiat Oncol Biol Phys. 1994;30(1):221–8.

    Article  CAS  PubMed  Google Scholar 

  10. Schafer C, Nelson K, Herbst M. Waiting for radiotherapy a national call for ethical discourse on waiting lists in radiotherapy: findings from a preliminary survey. Strahlentherapie und Onkologie. 2005;181(1):9–19.

    Article  PubMed  Google Scholar 

  11. Waaijer A, Terhaard CH, Dehnad H, Hordijk GJ, van Leeuwen MS, Raaymakers CP, et al. Waiting times for radiotherapy: consequences of volume increase for the TCP in oropharyngeal carcinoma. Radiother Oncol. 2003;66(3):271–6.

    Article  PubMed  Google Scholar 

  12. Mackillop WJ, Bates JH, O’Sullivan B, Withers HR. The effect of delay in treatment on local control by radiotherapy. Int J Radiat Oncol Biol Phys. 1996;34(1):243–50.

    Article  CAS  PubMed  Google Scholar 

  13. Webb S, Nahum AE. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phys Med Biol. 1993;38(6):653–66.

    Article  CAS  PubMed  Google Scholar 

  14. Fortin A, Bairati I, Albert M, Moore L, Allard J, Couture C. Effect of treatment delay on outcome of patients with early-stage head-and-neck carcinoma receiving radical radiotherapy. Int J Radiat Oncol Biol Phys. 2002;52(4):929–36.

    Article  PubMed  Google Scholar 

  15. •• Murphy CT, Galloway TJ, Handorf EA, Egleston BL, Wang LS, Mehra R, et al. Survival impact of increasing time to treatment initiation for patients with head and neck cancer in the United States. J Clin Oncol. 2016;34(2):169–78. A large database study showing that prolonged time to treatment initiation is affecting survival in head and neck cancer patients, with more than 60 days being consistently detrimental.

    Article  CAS  PubMed  Google Scholar 

  16. Bietendorf J. FDG PET reimbursement. J Nuclear Med Technol. 2004;32(1):33–8.

    Google Scholar 

  17. Cacicedo J, Fernandez I, Del Hoyo O, Dolado A, Gomez-Suarez J, Hortelano E, et al. Should PET/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma? A prospective analysis. Eur J Nucl Med Mol Imaging. 2015;42(9):1378–89.

    Article  PubMed  Google Scholar 

  18. Lonneux M, Hamoir M, Reychler H, Maingon P, Duvillard C, Calais G, et al. Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study. J Clin Oncol Off J Am Soc Clin Oncol. 2010;28(7):1190–5.

    Article  CAS  Google Scholar 

  19. Dinan MA, Curtis LH, Hammill BG, Patz EF Jr, Abernethy AP, Shea AM, et al. Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999–2006. JAMA. 2010;303(16):1625–31.

    Article  CAS  PubMed  Google Scholar 

  20. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29(32):4294–301.

    Article  Google Scholar 

  21. Wuthrick EJ, Zhang Q, Machtay M, Rosenthal DI, Nguyen-Tan PF, Fortin A, et al. Institutional clinical trial accrual volume and survival of patients with head and neck cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2015;33(2):156–64.

    Article  CAS  Google Scholar 

  22. Murphy CT, Galloway TJ, Handorf EA, Wang L, Mehra R, Flieder DB, et al. Increasing time to treatment initiation for head and neck cancer: an analysis of the National Cancer Database. Cancer. 2015;121(8):1204–13.

    Article  PubMed  Google Scholar 

  23. Smith BD, Haffty BG, Wilson LD, Smith GL, Patel AN, Buchholz TA. The future of radiation oncology in the United States from 2010 to 2020: will supply keep pace with demand? J Clin Oncol Off J Am Soc Clin Oncol. 2010;28(35):5160–5.

    Article  Google Scholar 

  24. Chen AY, Fedewa S, Pavluck A, Ward EM. Improved survival is associated with treatment at high-volume teaching facilities for patients with advanced stage laryngeal cancer. Cancer. 2010;116(20):4744–52.

    Article  PubMed  Google Scholar 

  25. Mell LK, Mehrotra AK, Mundt AJ. Intensity-modulated radiation therapy use in the U.S., 2004. Cancer. 2005;104(6):1296–303.

    Article  PubMed  Google Scholar 

  26. Ezzell GA, Galvin JM, Low D, Palta JR, Rosen I, Sharpe MB, et al. Guidance document on delivery, treatment planning, and clinical implementation of IMRT: report of the IMRT Subcommittee of the AAPM Radiation Therapy Committee. Med Phys. 2003;30(8):2089–115.

    Article  PubMed  Google Scholar 

  27. Guizard AV, Dejardin O, Launay L, Bara S, Lapotre-Ledoux B, Babin E, et al. What are the real waiting times for therapeutic management of head and neck cancer: a study in the general population in the north-west of France. Eur Arch Otorhinolaryngol. 2016;273(11):3951–8.

    Article  PubMed  Google Scholar 

  28. •• Sharma S, Bekelman J, Lin A, Lukens JN, Roman BR, Mitra N, et al. Clinical impact of prolonged diagnosis to treatment interval (DTI) among patients with oropharyngeal squamous cell carcinoma. Oral Oncol. 2016;56:17–24. NCDB study demonstrating socioeconomic status, academic setting, high volume, and IMRT as factors associated with increased diagnosis to treatment interval, correlating with survival outcomes.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Toto JM, Chang EI, Agag R, Devarajan K, Patel SA, Topham NS. Improved operative efficiency of free fibula flap mandible reconstruction with patient-specific, computer-guided preoperative planning. Head Neck. 2015;37(11):1660–4.

    Article  PubMed  Google Scholar 

  30. Wallace CG, Chang YM, Tsai CY, Wei FC. Harnessing the potential of the free fibula osteoseptocutaneous flap in mandible reconstruction. Plast Reconstr Surg. 2010;125(1):305–14.

    Article  CAS  PubMed  Google Scholar 

  31. Stitzenberg KB, Wong YN, Nielsen ME, Egleston BL, Uzzo RG. Trends in radical prostatectomy: centralization, robotics, and access to urologic cancer care. Cancer. 2012;118(1):54–62.

    Article  PubMed  Google Scholar 

  32. Yu X, Lum D, Kiet TK, Fuh KC, Orr J Jr, Brooks RA, et al. Utilization of and charges for robotic versus laparoscopic versus open surgery for endometrial cancer. J Surg Oncol. 2013;107(6):653–8.

    Article  PubMed  Google Scholar 

  33. Brouha XD, Tromp DM, Koole R, Hordijk GJ, Winnubst JA, de Leeuw JR. Professional delay in head and neck cancer patients: analysis of the diagnostic pathway. Oral Oncol. 2007;43(6):551–6.

    Article  CAS  PubMed  Google Scholar 

  34. Teppo H, Alho OP. Comorbidity and diagnostic delay in cancer of the larynx, tongue and pharynx. Oral Oncol. 2009;45(8):692–5.

    Article  PubMed  Google Scholar 

  35. Seoane J, Takkouche B, Varela-Centelles P, Tomas I, Seoane-Romero JM. Impact of delay in diagnosis on survival to head and neck carcinomas: a systematic review with meta-analysis. Clin Otolaryngol. 2012;37(2):99–106.

    Article  CAS  PubMed  Google Scholar 

  36. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Bilimoria KY, Ko CY, Tomlinson JS, Stewart AK, Talamonti MS, Hynes DL, et al. Wait times for cancer surgery in the United States: trends and predictors of delays. Ann Surg. 2011;253(4):779–85.

    Article  PubMed  Google Scholar 

  38. Leemans CR, Tiwari R, Nauta JJ, van der Waal I, Snow GB. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer. 1993;71(2):452–6.

    Article  CAS  PubMed  Google Scholar 

  39. Leemans CR, Tiwari R, Nauta JJ, van der Waal I, Snow GB. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer. 1994;73(1):187–90.

    Article  CAS  PubMed  Google Scholar 

  40. Kowalski LP, Carvalho AL. Influence of time delay and clinical upstaging in the prognosis of head and neck cancer. Oral Oncol. 2001;37(1):94–8.

    Article  CAS  PubMed  Google Scholar 

  41. van Harten MC, Hoebers FJ, Kross KW, van Werkhoven ED, van den Brekel MW, van Dijk BA. Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival. Oral Oncol. 2015;51(3):272–8.

    Article  PubMed  Google Scholar 

  42. Schrijvers CT, Coebergh JW, Mackenbach JP. Socioeconomic status and comorbidity among newly diagnosed cancer patients. Cancer. 1997;80(8):1482–8.

    Article  CAS  PubMed  Google Scholar 

  43. Siciliani L, Verzulli R. Waiting times and socioeconomic status among elderly Europeans: evidence from SHARE. Health Econ. 2009;18(11):1295–306.

    Article  PubMed  Google Scholar 

  44. Naghavi AO, Echevarria MI, Grass GD, Strom TJ, Abuodeh YA, Ahmed KA, et al. Having Medicaid insurance negatively impacts outcomes in patients with head and neck malignancies. Cancer. 2016.

  45. Albano JD, Ward E, Jemal A, Anderson R, Cokkinides VE, Murray T, et al. Cancer mortality in the United States by education level and race. J Natl Cancer Inst. 2007;99(18):1384–94.

    Article  PubMed  Google Scholar 

  46. Shavers VL, Harlan LC, Winn D, Davis WW. Racial/ethnic patterns of care for cancers of the oral cavity, pharynx, larynx, sinuses, and salivary glands. Cancer Metastasis Rev. 2003;22(1):25–38.

    Article  PubMed  Google Scholar 

  47. Rosenthal DI, Mohamed ASR, Garden AS, Morrison WH, El-Naggar AK, Kamal M, et al. Final report of a prospective randomized trial to evaluate the dose-response relationship for postoperative radiation therapy and pathologic risk groups in patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 2017;98(5):1002-11.

    Article  PubMed  Google Scholar 

  48. Vikram B, Strong EW, Shah J, Spiro RH. Elective postoperative radiation therapy in stages III and IV epidermoid carcinoma of the head and neck. Am J Surg. 1980;140(4):580–4.

    Article  CAS  PubMed  Google Scholar 

  49. Trotti A, Klotch D, Endicott J, Ridley M, Cantor A. Postoperative accelerated radiotherapy in high-risk squamous cell carcinoma of the head and neck: long-term results of a prospective trial. Head Neck. 1998;20(2):119–23.

    Article  CAS  PubMed  Google Scholar 

  50. Chen Z, King W, Pearcey R, Kerba M, Mackillop WJ. The relationship between waiting time for radiotherapy and clinical outcomes: a systematic review of the literature. Radiother Oncol. 2008;87(1):3–16.

    Article  PubMed  Google Scholar 

  51. Chen M, Jiang GL, Fu XL, Wang LJ, Qian H, Chen GY, et al. The impact of overall treatment time on outcomes in radiation therapy for non-small cell lung cancer. Lung Cancer. 2000;28(1):11–9.

    Article  PubMed  Google Scholar 

  52. Fyles A, Keane TJ, Barton M, Simm J. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol. 1992;25(4):273–9.

    Article  CAS  PubMed  Google Scholar 

  53. Kim JJ, Tannock IF. Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev Cancer. 2005;5(7):516–25.

    Article  CAS  PubMed  Google Scholar 

  54. Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 1988;27(2):131–46.

    Article  CAS  PubMed  Google Scholar 

  55. Ang KK, Trotti A, Brown BW, Garden AS, Foote RL, Morrison WH, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;51(3):571–8.

    Article  CAS  PubMed  Google Scholar 

  56. Rosenthal DI, Liu L, Lee JH, Vapiwala N, Chalian AA, Weinstein GS, et al. Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck. Head Neck. 2002;24(2):115–26.

    Article  PubMed  Google Scholar 

  57. • Shaikh T, Handorf EA, Murphy CT, Mehra R, Ridge JA, Galloway TJ. The impact of radiation treatment time on survival in patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 2016;96(5):967–75. A large database study showing prolonged treatment time in head and neck cancers is associated with worst overall survival, even with chemoradiation.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Cannon DM, Geye HM, Hartig GK, Traynor AM, Hoang T, McCulloch TM, et al. Increased local failure risk with prolonged radiation treatment time in head and neck cancer treated with concurrent chemotherapy. Head Neck. 2014;36(8):1120–5.

    Article  PubMed  Google Scholar 

  59. Lyhne NM, Christensen A, Alanin MC, Bruun MT, Jung TH, Bruhn MA, et al. Waiting times for diagnosis and treatment of head and neck cancer in Denmark in 2010 compared to 1992 and 2002. Eur J Cancer. 2013;49(7):1627–33.

    Article  CAS  PubMed  Google Scholar 

  60. Brouha X, Tromp D, Hordijk GJ, Winnubst J, De Leeuw R. Role of alcohol and smoking in diagnostic delay of head and neck cancer patients. Acta Otolaryngol. 2005;125(5):552–6.

    Article  PubMed  Google Scholar 

  61. Christophe V, Leroy T, Seillier M, Duthilleul C, Julieron M, Clisant S, et al. Determinants of patient delay in doctor consultation in head and neck cancers (Protocol DEREDIA). BMJ Open. 2014;4(7):e005286.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Tromp DM, Brouha XD, Hordijk GJ, Winnubst JA, de Leeuw JR. Patient factors associated with delay in primary care among patients with head and neck carcinoma: a case-series analysis. Fam Pract. 2005;22(5):554–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Dana-Farber/Brigham & Women’s Cancer Center, Harvard Medical School, Boston, MA, 02115, USA

    Muhammad M. Fareed MD

  2. Beth Israel Deaconess Medical Center, Harvard Medical School, 110 Francis Street, Boston, MA, 02120, USA

    Rizwan Ishtiaq MD

  3. Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, 19111, USA

    Thomas J. Galloway MD

Authors
  1. Muhammad M. Fareed MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rizwan Ishtiaq MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thomas J. Galloway MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Muhammad M. Fareed MD.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Head and Neck Cancer

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fareed, M.M., Ishtiaq, R. & Galloway, T.J. Testing the Timing: Time Factor in Radiation Treatment for Head and Neck Cancers. Curr. Treat. Options in Oncol. 19, 17 (2018). https://doi.org/10.1007/s11864-018-0534-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11864-018-0534-0

Keywords

Search

Navigation